Cell therapy weekly: US State lawmaker indicted for stem cell fraud scheme claiming to treat COVID-19

Written by RegMedNet

This week: a US State lawmaker has been indicted for a stem cell fraud scheme in which she made false claims about a supposed treatment at her medical clinics that could treat COVID-19, positive preliminary results have been reported from a Phase I trial of iNKT cell therapy in patients with mild-to-moderate symptoms of COVID-19, the US FDA clears an IND application for a stem cell-derived cell therapy to treat Type 1 diabetes, and Merck has entered into an agreement with Artiva Biotherapeutics to develop novel CAR-NK cell therapies targeting solid tumor-associated antigens. The news headlines: US State lawmaker indicted...

To view this content, please register now for access

It's completely free